Are Biosimilars as Effective as Brand Name Drugs?

Pharmaceutical spend is one of the biggest cost drivers for self-funded health plans, but thankfully, there are many opportunities for real savings. 

One effective tool to lower pharmacy spend is biosimilar medications. These lower-cost alternatives are slightly different from traditional generic medications, leading many people to ask: “Are biosimilars really as effective as brand-name drugs?”

In short, yes. Biosimilars are FDA-approved alternatives that meet rigorous standards to ensure they deliver the same clinical outcomes as their brand-name reference.

What is a biosimilar?

A biosimilar is a medication that is highly similar to an existing FDA-approved biologic drug, known as the reference drug. Biologic drugs are manufactured through living organisms (such as human, animal, or bacterial cells), not derived from chemicals. They treat a wide range of diseases including cancer, arthritis, and diabetes.

You may be familiar with generic drugs, which are exact copies of traditional brand-name chemical medications. Biosimilars work a little differently because they are based on a more complex biologic reference.

Due to their organic manufacturing process, biosimilars cannot be completely identical to their reference. Instead, manufacturers design biosimilars to perform identically to the original drug.

How are biosimilars approved?

Biosimilars undergo an extensive and rigorous review process to receive FDA approval and reach the market. In that process, studies must show that a biosimilar:

• Produces the same clinical outcomes as the reference drug

• Has no meaningful differences in safety or efficacy

• Delivers comparable quality and reliability

• Performs consistently across patient populations

Why biosimilars matter

Biosimilars often treat chronic and severe conditions, such as skin diseases, bowel diseases, diabetes, arthritis, and even some cancers. For employers and members, the brand-name versions of these medications can often be prohibitively expensive. 

Biosimilars help control specialty drug costs by providing lower-cost alternatives to some of the most expensive medications. This improves long-term plan sustainability without sacrificing clinical outcomes for members.

Biosimilars in an integrated pharmacy strategy

While biosimilars can deliver meaningful savings, they are most effective when their use is incorporated into a larger, holistic pharmacy management system.

Employers see the greatest pharmacy savings when they combine biosimilar adoption with:

• Transparent pharmacy pricing

• Utilization insight and management

• Specialty drug oversight

• Member navigation and support

These strategies, which are the foundation of VeracityRx, work together to control pharmacy costs holistically while prioritizing high-quality care.

The bottom line

Biosimilars are rigorously tested, FDA-approved medications that provide an important opportunity for employers to improve affordability without compromising clinical outcomes.

With VeracityRx’s integrated pharmacy solutions and biosimilars adoption strategy, employers can achieve meaningful savings and provide high-quality care.

‍